Clinical Research Directory
Browse clinical research sites, groups, and studies.
DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
Sponsor: David Blum
Summary
The aim of this study is to test if a system consisting of a wearable device measuring heartbeats and steps, together with daily communication with a chatbot on the smartphone asking the patients about their symptoms and giving tips, can reduce unplanned hospital readmissions and improve well-being in advanced cancer and severely ill patients.
Official title: DigiPall; a Randomized Controlled Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
382
Start Date
2025-06-11
Completion Date
2027-09
Last Updated
2025-07-10
Healthy Volunteers
No
Conditions
Interventions
DigiPall
DigiPall is an intervention combining a sensor-equipped wearable with a chatbot communicating via WhatsApp on the patient's smartphone. Patients will be asked two questions daily for their subjective rating through WhatsApp on their smartphone, worded slightly differently depending on the measured values for steps, heart rate and compliance as well as the patient's answer the day before.
Locations (1)
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland